Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

These Stocks Are Not Winning Today: Rewalk Robotics, Theravance Biopharma, Community Health Systems and More

Although the broader markets are in the green, shares of Rewalk Robotics Ltd (NASDAQ:RWLK), Theravance Biopharma Inc (NASDAQ:TBPH), AK Steel Holding Corporation (NYSE:AKS), Groupon Inc (NASDAQ:GRPN), and Community Health Systems (NYSE:CYH) are deep in the red this morning.

In this article, we’ll find out why traders are selling off the five stocks today and use 13F filings to determine how the smart money tracked by our team has been positioning themselves in them.

Our research determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor to beat the S&P 500 by around 95 basis points per month (see the details).

Top Selling Comic Book Characters of All Time
Rewalk Robotics Ltd (NASDAQ:RWLK) shares have plunged by 25.28% after the company announced a secondary offering of 3.25 million units at $3.75 per unit. Each unit consists of one ordinary share of the company, and 0.75 of a warrant to buy one ordinary share with an exercise price of $4.75. In addition, ReWalk has granted Oppenheimer & Co a 30-day option to buy an additional 487,500 units. The company intends to use the net proceeds from the offering for general corporate purposes. Only one of the funds that we track owned shares of Rewalk Robotics Ltd (NASDAQ:RWLK) at the end of June, that being D E Shaw (35,402 shares).

Follow Rewalk Robotics Ltd.
Trade (RWLK) Now!

Theravance Biopharma Inc (NASDAQ:TBPH) is 14% in the red after the biotech company announced a proposed public offering of $100 million of ordinary shares and another offering of $150 million of convertible senior notes due 2023. The company also intends to grant underwriters a 30-day option to buy up to an additional $15 million in ordinary shares and up to $22.5 million principal amount of additional notes. The exact pricing of the two offerings was not disclosed during the initial press release. Of the 749 hedge funds that we track which filed 13Fs for the June quarter, 12 funds owned $433.56 million worth of Theravance Biopharma Inc (NASDAQ:TBPH) shares on June 30, which accounted for 40.30% of the float and was up from nine funds with $298.66 million in holdings on March 31.

Follow Theravance Biopharma Inc. (NASDAQ:TBPH)
Trade (NASDAQ:TBPH) Now!

On the next page we’ll examine why traders are selling off Groupon, AK Steel, and Community Health Systems this morning.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.